Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma
Original Article
N.D. Gross, D.M. Miller, N.I. Khushalani, V. Divi, E.S. Ruiz, E.J. Lipson, F. Meier, Y.B. Su, P.L. Swiecicki, J. Atlas, J.L. Geiger, A. Hauschild, J.H. Choe, B.G. Hughes, D. Schadendorf, V.A. Patel, J. Homsi, J.M. Taube, A.M. Lim, R. Ferrarotto, H.L. Kaufman, F. Seebach, I. Lowy, S.-Y. Yoo, M. Mathias, K. Fenech, H. Han, M.G. Fury, and D. Rischin
N Engl J Med 2022;387:1557-1568
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Sunday, October 27, 2024 - 11:59pm.